Jeil Pharma Holdings Inc
KRX:002620.KS
8200 (KRW) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 794,713.611 | 792,964.733 | 762,568.056 | 761,996.752 | 731,140.38 | 142,736.343 | 44,440.577 | 617,279.88 | 594,715.655 | 512,736.239 | 451,968.239 | 426,819.209 | 462,853.352 | 431,307.03 | 369,486.923 | 319,439.855 | 305,027.902 |
| Cost of Revenue
| 592,891.628 | 612,481.608 | 582,061.262 | 570,757.448 | 549,162.617 | 86,278.85 | 23,133.368 | 482,154.814 | 454,500.267 | 383,860.835 | 342,551.577 | 319,038.595 | 329,679.984 | 297,369.591 | 248,373.494 | 224,114.006 | 208,135.013 |
| Gross Profit
| 201,821.983 | 180,483.126 | 180,506.794 | 191,239.304 | 181,977.762 | 56,457.492 | 21,307.209 | 135,125.066 | 140,215.388 | 128,875.404 | 109,416.662 | 107,780.614 | 133,173.368 | 133,937.439 | 121,113.429 | 95,325.849 | 96,892.889 |
| Gross Profit Ratio
| 0.254 | 0.228 | 0.237 | 0.251 | 0.249 | 0.396 | 0.479 | 0.219 | 0.236 | 0.251 | 0.242 | 0.253 | 0.288 | 0.311 | 0.328 | 0.298 | 0.318 |
| Reseach & Development Expenses
| 44,439.649 | 41,565.861 | 39,673.224 | 24,730.544 | 22,451.565 | 4,511.512 | 700.862 | 22,356.104 | 20,298.625 | 16,766.787 | 18,085.872 | 18,262.535 | 17,591.489 | 14,486.248 | 8,354.803 | 5,213.037 | 5,316.565 |
| General & Administrative Expenses
| 43,332.622 | 43,210.498 | 43,299.05 | 33,620.956 | 51,906.997 | 5,731.239 | 2,580.563 | 18,082.058 | 21,558.032 | 20,838.924 | 35,269.313 | 31,850.325 | 18,832.319 | 16,105.242 | 14,223.912 | 13,822.029 | 12,483.002 |
| Selling & Marketing Expenses
| 37,213.163 | 36,222.285 | 43,029.254 | 46,569.524 | 38,258.964 | 18,654.868 | 7,564.778 | 28,328.412 | 28,560.658 | 25,898.902 | 10,369.923 | 11,620.404 | 21,060.302 | 22,263.629 | 27,173.313 | 25,998.891 | 26,784.438 |
| SG&A
| 145,791.539 | 79,432.783 | 86,328.304 | 80,190.48 | 90,165.961 | 24,386.107 | 10,145.341 | 46,410.47 | 50,118.69 | 46,737.826 | 45,639.236 | 43,470.729 | 39,892.621 | 38,368.871 | 41,397.225 | 39,820.92 | 39,267.44 |
| Other Expenses
| 4,200.902 | 67,032.443 | 63,480.154 | 63,837.088 | 60,353.43 | 1,187.053 | 35.755 | 1,731.384 | 1,606.854 | 1,683.278 | 1,413.108 | 6,504.786 | 1,027.795 | -379.102 | 701.661 | 813.169 | -1,130.367 |
| Operating Expenses
| 190,231.188 | 188,031.087 | 189,481.682 | 168,758.112 | 172,970.956 | 45,508.085 | 21,015.059 | 125,771.904 | 127,066.954 | 120,324.177 | 108,043.895 | 101,460.358 | 101,671.065 | 92,771.582 | 82,572.408 | 79,649.396 | 79,101.222 |
| Operating Income
| 11,590.795 | -7,547.961 | 1,552.885 | 34,682.397 | 17,739.776 | 10,949.407 | 292.15 | 9,353.161 | 13,148.434 | 8,551.227 | 1,372.767 | 6,320.256 | 32,819.823 | 41,165.857 | 38,541.021 | 15,676.453 | 17,791.667 |
| Operating Income Ratio
| 0.015 | -0.01 | 0.002 | 0.046 | 0.024 | 0.077 | 0.007 | 0.015 | 0.022 | 0.017 | 0.003 | 0.015 | 0.071 | 0.095 | 0.104 | 0.049 | 0.058 |
| Total Other Income Expenses Net
| -34,901.836 | -76,312.665 | -7,682.087 | -3,860.715 | -100,339.44 | -1,161.432 | 3,245.11 | 4,449.224 | 2,901.228 | 3,283.083 | 725.227 | 7,307.76 | 5,808.215 | 4,384.147 | 5,431.785 | 11,010.777 | 7,326.381 |
| Income Before Tax
| -23,311.041 | -83,860.626 | -6,129.202 | 30,821.682 | -82,599.664 | 9,787.975 | 3,537.26 | 13,802.385 | 16,049.662 | 11,834.31 | 2,097.994 | 13,628.016 | 37,310.519 | 45,550.004 | 43,972.806 | 26,687.23 | 25,118.048 |
| Income Before Tax Ratio
| -0.029 | -0.106 | -0.008 | 0.04 | -0.113 | 0.069 | 0.08 | 0.022 | 0.027 | 0.023 | 0.005 | 0.032 | 0.081 | 0.106 | 0.119 | 0.084 | 0.082 |
| Income Tax Expense
| -740.818 | -715.62 | 6,740.804 | 15,880.621 | 13,254.347 | 2,486.346 | -489.51 | 5,912.13 | 6,288.291 | 9,738.85 | 1,613.608 | 2,456.179 | 10,295.73 | 20,079.804 | 15,974.556 | 9,152.407 | 11,444.035 |
| Net Income
| -16,249.744 | -83,145.006 | -12,870.005 | 11,431.126 | -95,854.011 | 7,069.964 | 518,816.622 | 7,890.255 | 9,761.371 | 2,095.459 | 484.386 | 11,171.838 | 27,014.788 | 25,470.2 | 27,998.25 | 17,534.823 | 13,674.013 |
| Net Income Ratio
| -0.02 | -0.105 | -0.017 | 0.015 | -0.131 | 0.05 | 11.674 | 0.013 | 0.016 | 0.004 | 0.001 | 0.026 | 0.058 | 0.059 | 0.076 | 0.055 | 0.045 |
| EPS
| -1,058.54 | -5,416.22 | -838.38 | 744.64 | -6,244.1 | 1,362.57 | 139,117 | 2,118.74 | 2,597.16 | 550.19 | 126.44 | 2,877.38 | 6,909.82 | 6,516.83 | 7,162.7 | 4,483.52 | 3,495.92 |
| EPS Diluted
| -1,058.54 | -5,416.22 | -838.38 | 744.64 | -6,244.1 | 1,362.57 | 139,117 | 2,118.74 | 2,597.16 | 550.19 | 126.44 | 2,877.38 | 6,909.82 | 6,516.83 | 7,162.7 | 4,483.52 | 3,495.92 |
| EBITDA
| 24,146.906 | -70,766.7 | 10,536.081 | 43,333.144 | 25,522.459 | 12,375.904 | 7,272.62 | 22,261.62 | 25,049.596 | 21,080.33 | 12,333.245 | 21,218.771 | 42,090.353 | 49,562.345 | 48,694.529 | 30,888.021 | 30,223.581 |
| EBITDA Ratio
| 0.03 | -0.089 | 0.014 | 0.057 | 0.035 | 0.087 | 0.164 | 0.036 | 0.042 | 0.041 | 0.027 | 0.05 | 0.091 | 0.115 | 0.132 | 0.097 | 0.099 |